---
$id: https://graph.org.ai/products/commodity/51131639
$type: Product
source: UNSPSC
code: "51131639"
title: "Fradafiban"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fradafiban

**UNSPSC Code**: 51131639
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent with the molecular formula C20H21N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQ0H2B8YKN, chemically known as (3s,5s)-5-(((4-amidino-4-biphenylyl)oxy)methyl)-2-oxo-3-pyrrolidineacetic acid but generally known as fradafiban, which bears US NIH Compound Identifier 66000. European Medicines Agency schedules Fradafiban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07813MIG. The term FRADAFIBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). FRADAFIBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fradafiban under HS 29337900 and SITC 51561. As of Q4 2014, FRADAFIBAN remains the US FDA Preferred Term for this commodity. Fradafiban bears US NLM identifiers UMLS ID C0665276 and NCI Concept Code C65769. SMILES: O(CC1NC(=O)C(C1)CC(=O)O)C1CCC(CC1)C1CCC(CC1)C(=N)N.

